InspireMD (NSPR) Cash from Operations Growth (1y) (2011 - 2025)
InspireMD (NSPR) Cash from Operations Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.60% |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | -38.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.44% |
| Sep 30, 2025 | -51.46% |
| Jun 30, 2025 | -91.39% |
| Mar 31, 2025 | -73.62% |
| Dec 31, 2024 | -61.60% |
| Sep 30, 2024 | -40.98% |
| Jun 30, 2024 | -30.95% |
| Mar 31, 2024 | -4.82% |
| Dec 31, 2023 | -30.74% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | -6.95% |
| Mar 31, 2023 | -16.86% |
| Dec 31, 2022 | -10.13% |
| Sep 30, 2022 | -23.29% |
| Jun 30, 2022 | -22.98% |
| Mar 31, 2022 | -13.54% |
| Dec 31, 2021 | -31.86% |
| Sep 30, 2021 | -36.01% |
| Jun 30, 2021 | -70.47% |
| Mar 31, 2021 | -54.67% |